Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Ann Neurol. 2011 Feb 18;69(5):866–871. doi: 10.1002/ana.22331

Table 1.

Clinical data on cases with DNA analysis

Patient Presentation Affected family
members*
CK (a) Clinical Course Death
1 (Lacson
case#1)
Female;
respiratory
distress at 7
weeks
Five siblings
died <2 months
age
20-fold Respiratory
insufficiency,
progressive muscle
rigidity
7 months
2 (Lacson
case #3)
Male; Weak cry
at 6 weeks
followed by
sudden death
5 month sibling ND Sudden death 6 weeks
3 (Lacson
case #6)
Female;
respiratory
distress at 8
weeks
None 20-fold Respiratory
insufficiency
3 months
4 Female; neonatal
apneic spells,
respiratory
distress at 2
months
2 month old
brother; possible
distant cousin
with same
surname
15-20
fold
Axial hypertonia,
rigidity of abdominal
wall, respiratory
insufficiency
3 months
5 Male; respiratory
distress at 11
weeks
One brother
died at 3 months
Truncal rigidity; alive at
4 years on mechanical
ventilation
-
6 Female; weakness
and sleep apnea
since birth
9 cousins died in
early infancy;
mother has mild
myopathic
symptoms but
normal CK
25-fold Diffuse hypertonia and
weakness; mechanical
ventilation
7.5 months
7 Female;
respiratory
distress
Cousins ND Rigidity of abdominal
wall, respiratory
insufficiency
3 months
8 Male; firm
abdomen and
viral pneumonia
at 2 months
Cousins ND Sudden death 2 months
*

Except for mother of patient 6, none of the parents reported weakness or had weakness on examination.

CK, creatine kinase, (a) reported as relative increase above the upper normal limit ND, not done